Financials

News Ideas Discussions Technicals Forecast Seasonals Options

NAMS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NewAmsterdam Pharma Company N.V. operating, investing, and financing activities

NAMS free cash flow for Q4 24 is -37.48 M USD. For 2024, NAMS free cash flow was -159.24 M USD and operating cash flow was -158.56 M USD.

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—